CBD-only laws are a pretext to extend marijuana prohibition under the guise of ‘protecting the children.’
The case of Jayden David, a child stricken with Dravet’s Syndrome, is instructive. In 2011, five-year-old Jayden, who had been on 22 pills per day, was given a CBD-infused tincture, which his father obtained from the Harborside Health Center, a medical marijuana dispensary in Oakland. The CBD remedy worked wonders. For the next several months the boy with intractable epilepsy was largely seizure-free. Featured on national television, the story of Jayden’s transformation was the first broadcast that drew attention to the remarkable medicinal properties of cannabidiol.
But the story doesn’t end there. In due course, it became evident to Jason David, Jayden’s devoted father, that sometimes his son responded better when more THC was added to the cannabis solution. If Jayden lived in a state with a CBD-only law rather than cutting edge California, he’d be out of luck, unable to legally access the medicine that keeps him alive. Many pediatric epilepsy patients would not be well served by CBD-only legislation. Nor would cancer patients, chronic pain suffers, and people with Alzheimer’s and autoimmune disorders.
Scientific research has established that CBD and THC interact synergistically and potentiate each other’s therapeutic effects. And marijuana contains several hundred other compounds, including flavonoids, terpenes, and dozens of minor cannabinoids in addition to CBD and THC. Each of these compounds has particular healing attributes, but when combined they create what scientists refer to as an “entourage effect,” so that the therapeutic impact of the whole plant exceeds the sum of its parts. Therein lies the basic fallacy of the CBD-only position.